Champions Oncology Inc (FRA:2I3)
€ 3.9 0.06 (1.56%) Market Cap: 56.35 Mil Enterprise Value: 60.26 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q4 2023 Champions Oncology Inc Earnings Call Transcript

Jul 24, 2023 / 08:30PM GMT
Release Date Price: €6.2 (+1.64%)
Operator

Greetings, and welcome to Champions Oncology's fourth quarter and fiscal year-end 2023 earnings conference call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, Ronnie Morris, CEO of Champions Oncology. You may begin.

Ronnie Morris
Champions Oncology, Inc. - President, CEO

Good afternoon. I am Ronnie Morris, CEO of Champions Oncology. Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call.

Before I begin, I will remind you that we'll be making forward-looking statements during today's call and that actual results could differ materially from what is described in those statements. Additional information on factors that could cause results to differ is available in our Forms 10-Q and Form 10-K. A reconciliation of non-GAAP financial measures that may be discussed during the call to GAAP

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot